This site is intended for Healthcare Professionals only.

NICE recommends new tablet for Uterine Fibroid relief

Share post:

Benger further added that “Uterine fibroids can cause a range of debilitating symptoms, including significant pain and heavy menstrual bleeding.
“If left untreated, these symptoms can lead to infertility and have a substantial impact on a woman’s quality of life.”
What causes Uterine fibroids?

Uterine fibroids are non-cancerous growths that develop in or around the uterus (womb).

Their exact cause is not known but they have been linked to oestrogen and progesterone.

Around 66 per cent of women develop at least 1 uterine fibroid during their lifetime and 33 per cent of women will develop symptoms from uterine fibroids. Most fibroids are small and do not cause symptoms.

However, some people with fibroids develop symptoms that can include very heavy or long menstrual periods or pelvic pressure or pain.

People with moderate to severe symptoms of uterine fibroids can experience a substantial negative effect on their quality of life.

Usual treatment for moderate to severe symptoms of uterine fibroids includes hormonal treatments, such as GnRH receptor agonists and antagonists, and supportive care.

How does it work?

Taken once a day as a single tablet, linzagolix (which is also called Yselty and made by Theramex) is a type of treatment called a GnRH antagonist.

It has been shown to be effective in reducing the bleeding caused by uterine fibroids, and also shrinking the fibroids themselves, compared with a dummy treatment.

It works by reducing the release of hormones which control oestrogen and progesterone production by the ovaries.

LEAVE A REPLY

Please enter your comment!
Please enter your name here